Idexx Laboratories Inc (IDXX): Shareholders' Equity
$1.61B
As of 2025-12-31
$1.61B
As of 2026-06-30
+38.2%
3-year compound annual growth
+20.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.61B | +0.6% | 2026-02-20, Balance as of period end |
| 2024-12-31 | $1.60B | +7.5% | 2026-02-20, Balance as of period end |
| 2023-12-31 | $1.48B | +143.9% | 2026-02-20, Balance as of period end |
| 2022-12-31 | $608.74M | -11.8% | 2025-02-21, Balance as of period end |
| 2021-12-31 | $689.99M | +9.2% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $632.09M | +256.2% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $177.47M | n/m | 2021-02-12, Balance as of period end |
| 2018-12-31 | -$9.51M | n/m | 2020-02-14, Balance as of period end |
| 2017-12-31 | -$54.11M | n/m | 2019-02-15, Balance as of period end |
| 2016-12-31 | -$108.35M | n/m | 2018-02-16, Balance as of period end |
| 2015-12-31 | -$84.12M | n/m | 2017-02-17, Balance as of period end |
| 2014-12-31 | $117.52M | -77.3% | 2016-02-17, Balance as of period end |
| 2013-12-31 | $518.19M | -18.6% | 2015-02-17, Balance as of period end |
| 2012-12-31 | $636.22M | +17.9% | 2014-02-18, Balance as of period end |
| 2011-12-31 | $539.58M | -6.0% | 2013-02-19, Balance as of period end |
| 2010-12-31 | $574.24M | +11.6% | 2012-02-17, Balance as of period end |
| 2009-12-31 | $514.57M | n/a | 2011-02-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.61B | +0.6% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $1.92B | -35.7% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $1.09B | +0.2% |
| Neogen Corp (NEOG) | 2026-05-31 | $2.09B | +1.0% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $368.00M | -47.5% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗